Form 4 for NEPH NEPHROS INC
Accepted 2023-12-15 00:00:00 ET · period of report 2023-12-13 · accession 0001062993-23-022643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-15 | 2023-12-13 | NEPH | Harris Joseph Michael | Dir | A - Grant | $0.00 | +9,291 | 17.7K | +111% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-13 | A | A | 9,291 | $0.00 | 17,693 | D | — | — | (F1) Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2023. These shares of restricted stock vest 6 months following the grant date. |